http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CY-1111991-T1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-503
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
filingDate 2011-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cefcbd88c0c94a33eaa66317669969f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33f276749dcc96b348440cbc98148eea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44f36c0bd83f48e230fc46a916454d55
publicationDate 2015-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CY-1111991-T1
titleOfInvention GLP-1 Protein Fusion Analogues
abstract The invention specifically provides GLP-1 analogs fused to specific lgG4-Fc derivatives. These fusion proteins have an increased half-life, reduced immunogenicity, and decrease active activity. Fusion proteins are useful in the treatment of diabetes, obesity, irritable bowel syndrome and other conditions that would benefit from lowering plasma glucose, inhibiting gastric and / or intestinal motility, and inhibiting gastric and / or intestinal emptying, or inhibition.
priorityDate 2003-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508054

Total number of triples: 29.